Results 111 to 120 of about 48,107 (253)

Selenium‐Based Nanoplatforms: An Emerging Theranostic Paradigm for Gynecological Cancers

Advanced Science, Volume 13, Issue 33, 15 June 2026.
This reivew summarizes Selenium as a multifunctional anticancer regulator in gynecological cancers. It reduces tumor risk, enhances therapeutic efficacy, and reduces treatment toxicity. Selenium also overcomes chemoraditherapy resistance, improving overall treatment outcomes. ABSTRACT Gynecological cancers present significant therapeutic challenges due
Hejing Liu, Yujia Zhou, Zihan Zhang, Rong Ma, Luyi Ruan, Liqing Miao, Boxin Zhang, Huihui Ji, Tianfeng Chen, Xueqiong Zhu   +9 more
wiley   +1 more source

Current status of brachytherapy in cancer treatment – short overview

, 2017
Cancer incidence and mortality depend on a number of factors, including age, socio-economic status and geographical location, and its prevalence is growing around the world.
Janusz Skowronek
core   +1 more source

[68Ga]Ga‐PSMA‐11 PET/CT for baseline staging of high‐risk prostate cancer: A real‐world study

BJUI Compass, Volume 7, Issue 6, June 2026.
Abstract Objective To use real‐world data to determine the clinical risk factors that are predictive of metastatic disease in high‐risk prostate cancer (PCa) patients undergoing staging [68Ga]Ga‐Prostate‐Specific Membrane Antigen (PSMA)‐11 positron emission tomography combined with computed tomography (PET/CT). Methods Subjects with newly diagnosed PCa
Amy Rose Sharkey, Paul Bassett, Manil Subesinghe, Gurdip Azad, Ajay Aggarwal, Simon Hughes, Prokar Dasgupta, Rick Popert, Ben Challacombe, Gary J. R. Cook   +9 more
wiley   +1 more source

A prospective longitudinal study of the changes in multidimensional fatigue and its associated factors in patients undergoing brachytherapy for cervical cancer

Scientific Reports
The changes of multidimensional fatigue and associated factors in patients undergoing brachytherapy for cervical cancer are unknown. This study aimed to evaluate changes in multidimensional fatigue with associated factors during and one month after the ...
Yifan Ye, Xiao Hu, Xinglan Zhang, Xiaojing Xu, Chunhong Wu, Aidi Ma, Xiaofen Qiu   +6 more
doaj   +1 more source

Treatment Advances in Gynecologic Cancers: Insights From Recent Clinical Trials

Cancer Innovation, Volume 5, Issue 3, June 2026.
Overview of immunotherapy and antibody‐drug conjugates, and their mechanism against cancer. (The Graphical Abstract Image was created with BioRender.) ABSTRACT Gynecologic cancers remain a major global health burden for women. Their management has evolved toward a gynecologic oncologist‐led multimodal paradigm.
Yiyang Shen, Xiaofei Jiao, Yuanjia Wen, Zikun Peng, Xuejiao Zhao, Jiahao Liu, Qinglei Gao   +6 more
wiley   +1 more source

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy

Prostate Cancer, 2016
Purpose. In this study, we evaluated our experience with salvage brachytherapy after discovery of biochemical recurrence after a prior brachytherapy procedure. Methods and Materials.
John M. Lacy, William A. Wilson, Raevti Bole, Li Chen, Ali S. Meigooni, Randall G. Rowland, William H. St. Clair   +6 more
doaj   +1 more source

Radiotherapy and Cardiovascular Disease Survival Risk in Non‐Small Cell Lung Cancer: A Population‐Based Study From the Surveillance, Epidemiology, and End Results Database

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background It is well known that radiotherapy increases the cardiovascular risk of cancer patients, but there are few large‐sample studies with cardiovasular‐specific death as the endpoint in lung cancer patients. Methods Patients aged ≥ 18 years diagnosed with non‐small cell lung cancer were retrospectively enrolled from the Surveillance ...
Chunhui Fan, Cuiping Hao, Li Liu, Mingyi Wen, Cunqi Li, Yian Geng, Wenxin Ren, Liping Zhang   +7 more
wiley   +1 more source

Amplifying radiation-induced anti-tumor immunity: the dual role of brachytherapy and low-dose total body irradiation

Frontiers in Immunology
BackgroundRadiotherapy can be a vaccine by triggering patients’ prophylactic tumor-specific immune responses. Brachytherapy has biological and physical benefits over external beam radiation.
YingQi Gu, YingQi Gu, Yang Yang, Jian Gao, ZhouXue Wu, Jia Wang, Chen Xie, XinYi Wang, Min Wu, YunXue Zheng, XiaoYin Zhang, Yue Chen, ShaoZhi Fu, ShaoZhi Fu, JingBo Wu, JingBo Wu, JingBo Wu   +16 more
doaj   +1 more source

Successful Treatment of Recurrent Hematometra With Ethanol Sclerotherapy: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT To our knowledge, this case report is the first to show that ethanol sclerotherapy can safely and effectively resolve recurrent hematometra caused by postradiotherapy stenosis and recurrent cervical cancer. For patients with poor overall condition in whom cervical drainage is not feasible, this minimally invasive approach may serve as a ...
Kojiro Tanabe, Fusako Komaru, Hirotaka Hamada, Hitoshi Niikura   +3 more
wiley   +1 more source

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions

, 2018
Beatrice Y Brewington,1 Yusra F Shao,2 Fredrick H Davidorf,1 Colleen M Cebulla1 1Havener Eye Institute, Department of Ophthalmology and Visual Science, Ohio State University, 2Medical Student Research Program, The Ohio State University College of ...
Cebulla CM, Yusra F Shao, Brewington BY, Beatrice Y Brewington, Frederick H Davidorf, Colleen M Cebulla, Davidorf FH, Shao YF   +7 more
core   +1 more source